Skip to main content
B

Besunyen Holdings Company Limited — Investor Relations & Filings

Ticker · 926 HKEX Manufacturing
Filings indexed 722 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country HK Hong Kong
Listing HKEX 926

About Besunyen Holdings Company Limited

http://ir.besunyen.com

Besunyen Holdings Company Limited, established in 2000, is a leading supplier of functional health teas and weight management products. The Group specializes in the research, development, manufacturing, and sales of therapeutic tea products primarily targeting the market in the People's Republic of China. Its product portfolio encompasses functional health teas, over-the-counter (OTC) medicines, including Besunyen Orlistat weight-loss medicines, as well as nutrition meal replacements, probiotics, and enzymes, positioning the company as a provider of comprehensive health and wellness solutions.

Recent filings

Filing Released Lang Actions
ANNUAL REPORT 2025
Regulatory Filings
2026-04-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is the monthly return (Form FF301) submitted to the Hong Kong Stock Exchange detailing movements in authorised/issued share capital, share options, public float confirmations, and other listing‐rule disclosures. This is a routine regulatory filing under the Exchange Listing Rules rather than an annual or interim financial report, earnings release, or capital raising announcement. There is no specific category for periodic share‐movement returns, so it falls under the fallback category of General Regulatory Filings (RNS).
2026-04-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Annual Report Classification · 1% confidence The document is an 'Annual Results Announcement' for Besunyen Holdings Company Limited for the year ended 31 December 2025. It contains comprehensive financial statements, including the consolidated statement of profit or loss, statement of financial position, and detailed notes to the financial statements. While it is titled an 'Announcement', it provides the full substantive financial data and analysis required for an annual reporting period, distinguishing it from a mere publication notice. Under the provided definitions, this constitutes an Annual Report (10-K) as it covers the full yearly financial performance. FY 2025
2026-03-22 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 1% confidence The document is a short announcement (1504 characters) from Besunyen Holdings Company Limited regarding the scheduling of a board meeting to approve upcoming financial results. It does not contain the financial results themselves, but rather notifies stakeholders of the date the results will be considered. This fits the definition of a Report Publication Announcement (RPA) or a general regulatory announcement regarding corporate events.
2026-03-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which is for specific events) or 'Transaction in Own Shares' (which is for buybacks), it is best classified as a Regulatory Filing (RNS).
2026-03-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited (HKEX). This is a standard regulatory filing required by the HKEX Listing Rules (specifically Rule 13.25C) to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory disclosure of share capital movements and does not fit into specific categories like 'Share Issue' (which usually implies a specific event) or 'Director's Dealing', it is best classified as a Regulatory Filing (RNS).
2026-02-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.